1) Taylor MJ1,2,3, Schils S4, Ruys AJ1. Home FES: An Exploratory Review. Eur J Transl Myol. 2019;29(4):8285. DOI:10.4081/ejtm.2019.8285. eCollection 2019 Oct 29.
2) Wing SS, Lecker SH, Jagoe RT. Proteolysis in illness-associated skeletal muscle atrophy: from pathways to networks. Critic Rev Clin Lab Sci. 2011;48:49-70. DOI:10.3109/10408363.2011.586171.
3) Ryall JG, Schertzer JD, Lynch GS. Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness. Biogerontology. 2008;9:213-228. DOI:10.1007/s10522-008-9131-0.
4) Janssen I., Heymsfield SB, Ross R. Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability. J Am Geriatrics Soc. 2002;50:889-896. DOI:10.1046/j.1532-5415.2002.50216.x.
5) Marzetti E, Calvani R, Bernabei R, Leeuwenburgh C. Apoptosis in skeletal myocytes: A potential target for interventions against sarcopenia and physical frailty – a mini-review. Gerontology. 2012;58:99-106. DOI:10.1159/000330064.
6) Puthucheary Z, Harridge S, Hart N. Skeletal muscle dysfunction in critical care: wasting, weakness, and rehabilitation strategies. Crit Care Med. 2010;38:S676-82. DOI:10.1097/CCM.0b013e3181f2458d.
7) Bossola M, Pacelli F, Tortorelli A, Rosa F, Battista Doglietto G. Skeletal muscle in cancer cachexia: the ideal target of drug therapy. Current Cancer Drug Targets. 2008;8:285-98. DOI:10.2174/156800908784533463.
8) Damrauer JS, Stadler ME, Acharyya S, Baldwin AS, Couch ME, Guttridge DC. Chemotherapy-induced muscle wasting: association with NF-κB and cancer cachexia. Eur J Transl Myol. 2018;28(2):7590. DOI:10.4081/ejtm.2018.7590. eCollection 2018 Apr 24.
9) Coletti D. Chemotherapy-induced muscle wasting: an update. Eur J Transl Myol. 2018;28(2):7587. DOI:10.4081/ejtm.2018.7587. eCollection 2018 Apr 24.
10) Zinna EM, Yarasheski KE. Exercise treatment to counteract protein wasting of chronic diseases. Curr Opin Clin Nutr Metabol Care. 2003;6:87-93. DOI:10.1097/01.mco. 0000049042.06038.b7
11) Patel DI, Abuchowski K, Sheikh B, Rivas P, Musi N, Kumar AP. Exercise preserves muscle mass and force in a prostate cancer mouse model. Eur J Transl Myol. 2019;29(4):8520. DOI:10.4081/ejtm.2019.8520. eCollection 2019 Oct 29.
12) Djemai H, Hassani M, Daou N, Li Z, Sotiropoulos A, Noirez P, Coletti D. Srf KO and wild-type mice similarly adapt to endurance exercise. Eur J Transl Myol. 2019;29(2):8205. DOI:10.4081/ejtm.2019.8205. eCollection 2019 May 7.
13) Fareed MU, Evenson AR, Wei W, Menconi M, Poylin V, Petkova V, Pignol B, Hasselgren PO. Treatment of rats with calpain inhibitors prevents sepsis-induced muscle proteolysis independent of atrogin-1/MAFbx and MuRF1 expression. Am J Physiol Regul Integr Comp Physiol. 2006;290:R1589-97. DOI:10.1152/ajpregu.00668.2005.
14) Baoge L, Van Den Steen E, Rimbaut S, Philips N, Witvrouw E, Almqvist KF, Vanderstraeten G, Vanden Bossche LC. Treatment of skeletal muscle injury: A review. ISRN Orthopedics. 2012. DOI:10.5402/2012/689012. eCollection 2012.
15) Guasconi V, Puri PL. Epigenetic drugs in the treatment of skeletal muscle atrophy. Curr Opin Clin Nutr Metab Care. 2008;11:233-41. DOI:10.1097/MCO.0b013e3282fa1810.
16) Smith RC, Lin BK. Myostatin inhibitors as therapies for muscle wasting associated with cancer and other disorders. Curr Opin. 2013;7(4):352-60. DOI:10.1097/SPC.0000000000000013.
17) Curran ME, Splawski I, Timothy KW, Vincent GM, Green ED, Keating MT. A molecular basis for cardiac arrhythmia: herg mutations cause long QT syndrome. Cell. 1995;80:795-803. PMID:7889573.
18) London B, Trudeau MC, Newton KP, Beyer AK, Copeland NG, Gilbert DJ, Jenkins NA, Satler CA, Robertson GA. Two isoforms of the mouse Ether-a-go-go-related gene coassemble to form channels with properties similar to the rapidly activating component of the cardiac delayed rectifier K+ current. Circ Res. 1997;81:870-878. DOI:10.1161/01.RES.81.5.870.
19) Lees-Miller JP, Kondo C, Wang L, Duff HJ. Electrophysiological characterization of an alternatively processes erg K+ channel in mouse and human hearts. Circ Res. 1997;81:719-726. DOI:10.1161/01.RES.81.5.719.
20) Guasti L, Cilia E, Crociani O, Hofmann G, Polvani S, Becchetti A, Wanke E, Tempia F, Arcangeli A. Expression pattern of the ether-a-go-go-related (ERG) family proteins in the adult mouse central nervous system: Evidence for coassembly of different subunits. J Comp Neurol. 2005;491(2):157-174. DOI:10.1002/cne.20721.
21) Babcock JJ, Li M. hERG channel function: beyond long QT. Acta Pharm Sinica. 2013;34:329-335. DOI:10.1038/aps.2013.6.
22) Phartiyal P, Jones EM, Robertson G. Heteromeric assembly of human ether-a-gogo-related (hERG) K+ channels occurs cotranslationally via N-terminal interactions. J Biol Chem. 2007; 282:9874-9882. DOI:10.1074/jbc.M610875200.
23) Jones EMC, Roti EC, Wang J, Delfosse SA, Robertson GA. Cardiac IKr channels minimally comprise hERG1a and 1b subunits. JBC. 2004;279(43):44690-44694. DOI:10.1074/jbc.M408344200.
24) Wang X, Hockerman GH, Green 3rd HW, Babbs CF, Mohammad SI, Gerrard D, Latour MA, Hannon KM, Pond AL. Merg1a K+ channel induces skeletal muscle atrophy by activating the ubiquitin proteasome pathway. FASEB J. 2006;20(9):1531-3. DOI:10.1096/fj.05-5350fje.
25) Selyanko AA, Delmas P, Hadley JK, Tatulian L, Wood IC, Mistry M, London B, Brown DA. Dominant-negative subunits reveal potassium channel families that contribute to M-like potassium currents. J Neurosci. 2002;22: RC212-217.
26) Hockerman GH, Dethrow NM, Hameed S, Doran M, Jaeger C, Wang W-H, Pond AL. The Ubr2 gene is expressed in skeletal muscle atrophying as a result of hind limb suspension, but not Merg1a expression alone. Eur J Trans Myol. 2014; 24(3):173-179. DOI:10.4081/ejtm.2014.3319.
27) Pond AL, Nedele C, Wang W-H, Wang X, Walther C, Jaeger C, Bradley KS, Du H, Fujita N, Hockerman GH, Hannon KM. The MERG1a channel modulates skeletal muscle Murf1, but not MAFbx, expression. Muscle & Nerve. 2013;49(3):378-388. DOI:10.1002/mus.23924.
28) Fearon K, Trasser F, Anker SD, Bosaeus I, Bruera E, Fainsinger RL, Jatoi A, Loprinzi C, MacDonald N, Mantovani G, David M, Muscaritoli M, Ottery F, Radbruch L, Ravasco P, Walsh D, Wilcock A, Kaasa S, Baracos VE. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;2:489-495.
29) Fischman DA. Immunochemical analysis of myosin heavy chain during avian myogenesis in vivo and in vitro. J Cell Biol. 1982;95(3):763-70.
30) Pond AL, Petrecca K, Van Wagoner DR, Shrier A, Nerbonne JM. Expression of distinct ERG1 proteins in rat, mouse and human heart: Relation to functional IKr channels. JBC. 2000;275:5997-6006. DOI:10.1074/jbc.275.8.5997.
31) Schneider CA, Rasband WS, Eliceiri KW. "NIH Image to ImageJ: 25 years of image analysis", Nature Methods. 2012;9(7):671-675. PMID 22930834.
32) Cheatwood JL, Emerick AJ, Schwab ME, Kartje GL. Nogo-A expression after focal ischemic stroke in the adult rat. Stroke. 2008; 39:2091-2098. DOI:10.1161/STROKEAHA.107.507426.
33) Miljkovic N, Lim J-Y, Miljkovic I, Frontera WR. Aging of skeletal muscle fibers. Ann Rehabil Med. 2015;39(2):155-162. DOI:10.5535/arm.2015.39.2.155.
34) Rasmussen HB, Moller M, Knaus H-G, Jensen BS, Olesen S-P, Jorgensen NK. Subcellular localization of the delayed rectifier K+ channels KCNQ1 and ERG1 in the rat heart. Am J Physiol Heart Circ Physiol. 2004;286:H1300-H1309. DOI:10.1152/ajpheart.00344.2003.
35) Protasi F. Structural interaction between RYRs and DHPRs in calcium release units of cardiac and skeletal muscle cells. Front Biosci. 2002;7:d650-658. PMID:11861217.
36) Jayasinghe ID, Launikonis BS. Three-dimensional reconstruction and analysis of the tubular system of vertebrate skeletal muscle. J Cell Science 2013;126:4048-4058.
37) Goll DE, Dayton WR, Singh I, Robson RM. Studies of the a-actinin/atin interactions in the Z-disk by using calpain. J Biol Chem 1991;266(13):8501-8510.
38) Wang X, Xu R, Abernathy GT, Taylor J, Alzghoul MB, Hannon K, Hockerman GH, Pond AL. Kv11.1 K+ channel composition varies developmentally in mouse heart. Dev Dynamics. 2007;237:2430-2437. DOI:10.1002/dvdy.21671.
39) Van Wagoner DR, Pond AL, Lamorgese M, Rossie SS, McCarthy PM, Nerbonne JM. Atrial L-type Ca2+ currents and human atrial fibrillation. Circ Res. 1999;85:428-436. DOI:10.1161/01.RES.85.5.428
40) Wang Z, Feng J, Shi J, Pond AL, Nerbonne JM, Nattel S. Potential molecular basis of different physiological properties of transient outward current in rabbit and human atrial myocytes. Circ Res. 1999;84:551-561. DOI:10.1161/01.RES.84.5.551
41) Anderson LB, Latour CD, Khader O, Massey BH, Cobb B, Pond AL. Ether-a-go-go related gene-1a potassium channel abundance varies within specific skeletal muscle fiber type. Euro J Transl Myol 2019;29(3):8402. DOI:10.4081/ejtm.2019.8402. eCollection 2019 Aug 2.
42) Bonaldo P, Sandri M. Cellular and molecular mechanisms of muscle atrophy. Disease Models & Mechs. 2013;6:25-39. DOI:10.1242/dmm.010389.
43) Whitmore C, Pratt EPS, Anderson LB, Bradley K, Latour SM, Hashmi MN, Urazaev AK, Weilbaecher R, Davie JK, Wang W-H, Hockerman GH, Pond AL. The ERG1a potassium channel increses basal intracellular concentration and calpain activity in skeletal muscle cells. Skeletal Muscle. 2020;10(1). DOI: 10.1186/s13395-019-0220-3.
44) Sanguinetti MC, Curran ME, Spector PS, Keating MT. Spectrum of HERG K+-channel dysfunction in an inherited cardiac arrhythmia. PNAS USA. 1996;93:2208-2212. PubMed ID8700910
45) Pederson TH, Riisager A, de Paoli FV, Cehn T-Y, Nielsen OB. Role of physiological ClC-1Cl- ion channel regulation for the excitability and function of working skeletal muscle. J Gen Physiol. 2016;147(4):291-308. DOI:10.1085/jgp.201611582.
46) Renganathan M, Messi ML, Delbono O. Dihydropyridine receptor-ryanodine receptor uncoupling in aged skeletal muscle. J Membr Biol. 1997;157:247–253. DOI:10.1007/s002329900233.
47) Boncompagni S, d'Amelio L, Fulle S, Fanò G, Protasi F. Progressive disorganization of the excitation-contraction coupling apparatus in aging human skeletal muscle as revealed by electron microscopy: a possible role in the decline of muscle performance. J Gerontol A Biol Sci Med Sci. 2006;61(10):995-1008. DOI:10.1093/gerona/61.10.995.
48) Delbono O. Regulation of excitation contraction coupling by insulin-like growth factor-1 in aging skeletal muscle. J Nutr Health Aging. 2000;4:162–164. PMID:10936903.